| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/05/2007 | WO2007038045A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | WO2007038036A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037265A1 Dna vaccine composition |
| 04/05/2007 | WO2007037258A1 Therapeutic agent for attention deficit/hyperactivity disorder |
| 04/05/2007 | WO2007037245A1 Polypeptide having anti-angiogenic activity |
| 04/05/2007 | WO2007037133A1 Method for evaluation of compound capable of acting on plk3 |
| 04/05/2007 | WO2007036781A1 Diphenyl ether monoamine reuptake inhibitor |
| 04/05/2007 | WO2007036718A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/05/2007 | WO2007036715A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/05/2007 | WO2007036711A1 BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR |
| 04/05/2007 | WO2007036599A1 New crystallization process of quetiapine hemifumarate |
| 04/05/2007 | WO2007036033A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 04/05/2007 | WO2007021575A3 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 04/05/2007 | WO2007020386A3 Apoe mimetic agents |
| 04/05/2007 | WO2007016012A3 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION |
| 04/05/2007 | WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/05/2007 | WO2007009724A3 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007009723A3 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/05/2007 | WO2007006922A3 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers |
| 04/05/2007 | WO2007000392A3 Chloro-substituted guanidines |
| 04/05/2007 | WO2006134457A3 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives |
| 04/05/2007 | WO2006130522A3 Methods and compositions for managing psychotic disorders |
| 04/05/2007 | WO2006122652A3 Thiosuccinic acid derivatives and the use thereof |
| 04/05/2007 | WO2006109195A3 Modulation of an immune response by filamentous haemagglutinin |
| 04/05/2007 | WO2006100075A3 Use of an artificial sweetener to enhance absorption of nicotine |
| 04/05/2007 | WO2006099468A3 Process for the purification of duloxetine hydrochloride |
| 04/05/2007 | WO2006083682A3 Polymorphic forms of a gabaa agonist |
| 04/05/2007 | WO2006078554A3 Cgrp receptor antagonists |
| 04/05/2007 | WO2006026820A9 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 04/05/2007 | WO2005067969A3 Combinations of serotonin reuptake inhibitors and imidazoline-i2-agonists |
| 04/05/2007 | US20070079389 Method for screening PTPzeta activity promoter or inhibitor |
| 04/05/2007 | US20070078283 Reacting 1-bromo-3,5-dimethyl adamantane and urea/formic acid, with formic acid also acting as the solvent; hydrolyzing with aqueous inorganic acid; alkalifying, and extracting and acidifying with hydrochloric acid; performed in homogeneous phase under mild conditions |
| 04/05/2007 | US20070078183 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070078137 Method of inhibiting neurotrophin-receptor binding |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078099 Method of preventing, treating and diagnosing disorders of protein aggregation |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | CA2664629A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | CA2623745A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | CA2623525A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | CA2623245A1 Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 04/05/2007 | CA2623210A1 Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients |
| 04/05/2007 | CA2623204A1 Combination of rosiglitazone and donepezil for improvement of cognitive function |
| 04/05/2007 | CA2623072A1 Use of ibudilast for treating drug and behavioral addictions |
| 04/05/2007 | CA2623047A1 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine |
| 04/05/2007 | CA2622701A1 Amino-aza-adamantane derivatives and methods of use |
| 04/05/2007 | CA2622677A1 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770093A1 Pyrido¬2,3-d|pyrimidine derivatives as phosphodiesterase inhibitors |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769798A1 New association of agomelatine and a noradrenalin reuptake inhibitor, and pharmaceutical compositions containing them |
| 04/04/2007 | EP1769794A1 Medicament for preventing and/or treating sleep disorder |
| 04/04/2007 | EP1769791A2 Treatment of Alzheimer's disease with cell cycle inhibitors |
| 04/04/2007 | EP1769790A1 Preparations for the intranasal application of selected CGRP antagonists derived from amino acids |
| 04/04/2007 | EP1768979A1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 04/04/2007 | EP1768970A1 Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders |
| 04/04/2007 | EP1768968A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 04/04/2007 | EP1768960A1 Sulfonamide derivatives |
| 04/04/2007 | EP1768958A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| 04/04/2007 | EP1768951A2 Non-natural amino acids |
| 04/04/2007 | EP1768948A1 Substituted amino compounds as 5-ht/na uptake inhibitors |
| 04/04/2007 | EP1768674A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 04/04/2007 | EP1768670A1 Use of flibanserin for the treatment of anorexia nervosa |
| 04/04/2007 | EP1768653A2 Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia |
| 04/04/2007 | EP1562932B1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
| 04/04/2007 | EP1551793A4 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/04/2007 | EP1545546B1 Treatment of dyskinesia with 2,3-benzodiazepines |
| 04/04/2007 | EP1545537B1 Alpha-7 nicotinic receptor agonists and statins in combination |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/04/2007 | EP1331932B1 Use of xestospongin c for treating or preventing hiv infection |
| 04/04/2007 | EP1307205B1 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/04/2007 | EP1239861B1 Combination of cyamemazine and an atypical neuroleptic |
| 04/04/2007 | EP1098642B1 Diamino-propanol-compounds for treating ischemia |
| 04/04/2007 | EP0969835B1 Use of central cannabinoid receptor antagonists for regulating appetency |
| 04/04/2007 | CN1942185A Treatment of impaired respiratory function with gaboxadol |
| 04/04/2007 | CN1942184A Niosame having metal porphyrin complex embedded therein, process for it and drug with use thereof |
| 04/04/2007 | CN1942181A Tablet containing branched chain amino acid and process for producing the same |
| 04/04/2007 | CN1942180A Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
| 04/04/2007 | CN1942179A Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1939920A Eastern poppy base compound and its medical use |
| 04/04/2007 | CN1939918A Production of midanping |
| 04/04/2007 | CN1939895A Compound, composition and method for preventing from neurodegeneration in injury of central nervous system |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939538A Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 04/04/2007 | CN1939533A Injection sarcosine peptide aglycone powdery injection and its making method |
| 04/04/2007 | CN1939529A Compositions and methods for modulating connexin hemichannels |
| 04/04/2007 | CN1939520A Yizhi capsule for improving memory and its production |
| 04/04/2007 | CN1939515A Abstinence Chinese-medicinal preparation and its making method |
| 04/04/2007 | CN1939485A Chinese-medicinal composition for treating depression by meridian tropism |
| 04/04/2007 | CN1939439A Juglone and jujube capsules with memory-improving function and preparation thereof |